Effective Use of Zoledronic Acid for Refractory Hypercalcemia in Neonatal Subcutaneous Fat Necrosis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Stefanko N, Drolet B
. Subcutaneous fat necrosis of the newborn and associated hypercalcemia: A systematic review of the literature. Pediatr Dermatol. 2018; 36(1):24-30.
DOI: 10.1111/pde.13640.
View
2.
Chesover A, Harrington J, Mahmud F
. Pamidronate as first-line treatment of hypercalcemia in neonatal subcutaneous fat necrosis: A case series. Paediatr Child Health. 2021; 26(1):e52-e56.
PMC: 7850270.
DOI: 10.1093/pch/pxz141.
View
3.
Militello M, Re M, Vitaliti G, Finazzo F, Manzoni P, Vitaliti S
. Use of Zoledronic Acid in a Neonate with Subcutaneous Fat Necrosis Complicated with Severe, Refractory Hypercalcemia. Am J Perinatol. 2019; 36(S 02):S134-S138.
DOI: 10.1055/s-0039-1691777.
View
4.
Bowden S, Mahan J
. Zoledronic acid in pediatric metabolic bone disorders. Transl Pediatr. 2017; 6(4):256-268.
PMC: 5682380.
DOI: 10.21037/tp.2017.09.10.
View